Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9817 - 9824 of 11442 results
IRS Begins Audit of Deferred Compensation Plans Subject to Section 409A
June 2, 2014| Blog| Viewpoint
Keeping Legal Advice In-House: Protecting the Attorney-Client Privilege
June 2, 2014| Blog| Viewpoint
Privacy Monday - June 2, 2014
June 2, 2014| Blog| Viewpoint
Check Your CAP: CPSC Releases Revised Monthly Progress Report Form for Recalls
May 30, 2014| Blog| Viewpoint
Using Corporate Bylaws and Charters to Set the Rules for Shareholder Litigation
May 30, 2014| Blog| Viewpoint
Waivers of Age Discrimination Claims in Reduction in Force Cases Continue to Face Intense Scrutiny
May 29, 2014| Blog| Viewpoint
Mintz’s Health Care Qui Tam Update
May 29, 2014| Blog| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.